MCID: PRT036
MIFTS: 63

Peritonitis malady

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Peritonitis

Aliases & Descriptions for Peritonitis:

Name: Peritonitis 12 52 14 69
Retractile Mesenteritis 12 50 69
Sclerosing Mesenteritis 12 50 69
Peritoneal Retractile Mesenteritis 50 69
Acute Generalized Peritonitis 12 69
Primary Bacterial Peritonitis 12 69
Mesenteric Panniculitis 50 69
Idiopathic Sclerosing Mesenteritis 50
Liposclerotic Mesenteritis 50
Mesenteric Lipodystrophy 50
Mesenteric Lipogranuloma 50
Mesenteric Fibromatosis 50
Fibromatosis, Abdominal 69

Classifications:



External Ids:

Disease Ontology 12 DOID:8283
ICD9CM 35 567.8 567.89
SNOMED-CT 64 197183001 197187000
ICD10 33 K65 K65.9
UMLS 69 C0029823

Summaries for Peritonitis

Disease Ontology : 12 A gastrointestinal system disease that involves inflammation of the peritoneum resulting from perforation of the gastrointestinal tract, which produces immediate chemical inflammation followed shortly by infection from intestinal organisms. Peritonitis can also result from appendicitis, diverticulitis, strangulating intestinal obstruction, pancreatitis, pelvic inflammatory disease, mesenteric ischemia, intraperitoneal blood, barium, or peritoneo-systemic shunts, drains, and dialysis catheters in the peritoneal cavity. The symptoms include abdominal pain and tenderness, fever, fluid in the abdomen, nausea, vomiting and low urine output.

MalaCards based summary : Peritonitis, also known as retractile mesenteritis, is related to tuberculosis and hepatitis. An important gene associated with Peritonitis is ALB (Albumin), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Erythromycin and Ciprofloxacin have been mentioned in the context of this disorder. Affiliated tissues include liver, endothelial and colon, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and homeostasis/metabolism

NIH Rare Diseases : 50 sclerosing mesenteritis is one of many terms used to describe a spectrum of chronic inflammatory diseases affecting the small bowel mesentery, the membrane that anchors the small intestine to the back of the abdominal wall. the cause of this condition is unknown. the most common symptom is abdominal pain or a palpable abdominal mass. click on the highlighted text to view an illustration of the small intestine. last updated: 11/6/2016

Wikipedia : 71 Peritonitis is an inflammation of the peritoneum, the thin tissue that lines the inner wall of the... more...

Related Diseases for Peritonitis

Diseases related to Peritonitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 946)
id Related Disease Score Top Affiliating Genes
1 tuberculosis 30.4 CCL2 IL10 IL1B IL6 TNF
2 hepatitis 30.3 IFNG IL10 IL6 TNF
3 congestive heart failure 29.8 IFNG IL10 IL6 TNF
4 intussusception 29.7 IL1B TNF
5 neuropathy 29.7 CRP CXCL8 IL1B IL6 TNF
6 clostridium difficile colitis 29.7 IFNG IL6 TNF
7 ischemic optic neuropathy 29.5 ALB CRP F2 IL6
8 carbuncle 29.5 CXCL8 IL1B IL6
9 fasciitis 29.4 CXCL8 TLR2 TNF
10 hemolytic-uremic syndrome 29.4 ALB F2 IFNG TNF
11 calcinosis 29.4 ALB B2M CCL2 CRP IL6 TGFB1
12 gastric dilatation 29.4 CXCL8 IL10 IL6 TNF
13 capillary leak syndrome 29.3 ALB CRP CXCL8
14 hemangioma of spleen 29.3 CRP IFNG IL6
15 pulmonary tuberculosis 29.3 CXCL8 IFNG IL10 IL6 TNF
16 colon adenocarcinoma 29.3 ALB CRP CXCL8 IL10 IL1B IL6
17 granulomatous hepatitis 29.2 CRP F2 IL1B IL6
18 uveitis 29.2 CCL2 ICAM1 TNF
19 cataract 29.2 ALB CRP IL1B TNF
20 adrenal adenoma 29.2 CCL2 CRP IL6 TNF
21 loiasis 29.2 IFNG IL10 TGFB1
22 breast reconstruction 29.1 IL10 IL1B IL6
23 elephantiasis 29.1 ADA IFNG IL10
24 xanthogranulomatous cholecystitis 29.1 CXCL8 ICAM1 IL10 TNF
25 bacterial meningitis 29.0 ALB CRP F2 IL6 TNF
26 ovarian cystic teratoma 29.0 CXCL8 IL1B TLR2 TNF
27 dengue hemorrhagic fever 29.0 IFNG IL10 TLR2 TNF
28 alcoholic hepatitis 28.9 CXCL8 F2 IL10 IL6 TNF
29 membranoproliferative glomerulonephritis 28.8 ALB CRP F2 IL10 IL6 TNF
30 collagenous colitis 28.8 CRP CXCL8 ICAM1 IFNG IL10 IL1B
31 periarthritis 28.8 ADA IFNG IL10 TLR2 TNF
32 choroiditis 28.7 ALB CCL2 CRP CXCL8 IL10 IL1B
33 rheumatoid arthritis 28.5 CCL2 CRP CXCL8 ICAM1 IFNG IL10
34 asbestosis 28.1 ALB CRP CXCL8 F2 IL10 IL6
35 von hippel-lindau syndrome 28.0 ALB CCL2 CRP F2 ICAM1 IFNG
36 primary peritoneal carcinoma 12.2
37 peritoneal mesothelioma 12.2
38 benign multicystic peritoneal mesothelioma 12.2
39 disseminated peritoneal leiomyomatosis 12.1
40 tuberculous peritonitis 12.1
41 diphtheritic peritonitis 12.0
42 malignant peritoneal mesothelioma 11.9
43 peritoneal cystic mesothelioma 11.9
44 acute female pelvic peritonitis 11.9
45 benign peritoneal mesothelioma 11.9
46 peritoneal serous papillary adenocarcinoma 11.8
47 primary peritoneal serous/papillary carcinoma 11.8
48 diffuse peritoneal leiomyomatosis 11.8
49 peritoneal serous adenocarcinoma 11.8
50 appendicitis 11.7

Comorbidity relations with Peritonitis via Phenotypic Disease Network (PDN): (show all 13)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Chronic Kidney Failure
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Intestinal Obstruction
Intestinal Perforation Mesenteric Artery Ischemia
Paralytic Ileus Protein-Energy Malnutrition
Respiratory Failure

Graphical network of the top 20 diseases related to Peritonitis:



Diseases related to Peritonitis

Symptoms & Phenotypes for Peritonitis

GenomeRNAi Phenotypes related to Peritonitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.83 F2 ICAM1 IL10 IL1B TGFB1 TNF
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.83 ICAM1 IL10 IL1B TGFB1 TNF AQP1

MGI Mouse Phenotypes related to Peritonitis:

44 (show all 15)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.4 ADA ALB AQP1 B2M CRP F2
2 cardiovascular system MP:0005385 10.39 CXCL2 F2 ICAM1 IFNG IL10 IL1B
3 hematopoietic system MP:0005397 10.36 ADA AQP1 B2M F2 ICAM1 IFNG
4 immune system MP:0005387 10.35 ADA B2M CCL2 CRP F2 ICAM1
5 digestive/alimentary MP:0005381 10.28 ADA ALB B2M F2 ICAM1 IFNG
6 endocrine/exocrine gland MP:0005379 10.26 ADA ALB AQP1 B2M ICAM1 IFNG
7 mortality/aging MP:0010768 10.22 ADA ALB AQP1 B2M F2 ICAM1
8 integument MP:0010771 10.16 B2M F2 ICAM1 IFNG IL10 IL1B
9 liver/biliary system MP:0005370 10.13 TNF ADA ALB B2M IFNG IL10
10 nervous system MP:0003631 10.03 AQP1 B2M F2 ICAM1 IFNG IL10
11 muscle MP:0005369 10.02 ADA ALB ICAM1 IFNG IL10 IL6
12 neoplasm MP:0002006 10.02 IFNG IL10 IL1B IL6 TGFB1 TLR2
13 reproductive system MP:0005389 9.81 ADA AQP1 B2M F2 IFNG IL10
14 respiratory system MP:0005388 9.61 ADA TGFB1 TLR2 TNF AQP1 F2
15 skeleton MP:0005390 9.32 IL1B IL6 TGFB1 TLR2 TNF ADA

Drugs & Therapeutics for Peritonitis

Drugs for Peritonitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 250)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Erythromycin Approved, Vet_approved Phase 4 114-07-8 12560
2
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
3
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
4
Enalaprilat Approved Phase 4 76420-72-9 6917719
5
Losartan Approved Phase 4 114798-26-4 3961
6
Spironolactone Approved Phase 4 1952-01-7, 52-01-7 5833
7
Hydralazine Approved Phase 4 86-54-4 3637
8
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
9
Ceftriaxone Approved Phase 4,Phase 3 73384-59-5 5479530 5361919
10
Propranolol Approved, Investigational Phase 4,Phase 3 525-66-6 4946
11
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
12
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
13
Vancomycin Approved Phase 4,Phase 2,Phase 3 1404-90-6 441141 14969
14
Metronidazole Approved Phase 4,Phase 3,Phase 2 443-48-1 4173
15
Norfloxacin Approved Phase 4,Phase 2,Phase 3 70458-96-7 4539
16
Imipenem Approved Phase 4,Phase 3 74431-23-5 104838
17
Cefotaxime Approved Phase 4,Phase 3 63527-52-6 456256 5742673
18
Cefazolin Approved Phase 4,Phase 3 25953-19-9 656510 33255
19
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
20
Mupirocin Approved, Investigational, Vet_approved Phase 4 12650-69-0 446596
21
Menthol Approved Phase 4 2216-51-5 16666
22
Ceftazidime Approved Phase 4,Phase 2,Phase 3 78439-06-2 5481173
23
Cefoxitin Approved Phase 4,Phase 3 35607-66-0 441199
24
Ertapenem Approved, Investigational Phase 4,Phase 2 153832-46-3 150610
25
Heparin Approved, Investigational Phase 4,Phase 2 9005-49-6 772 46507594
26
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
27
Icodextrin Approved, Investigational Phase 4,Phase 2 337376-15-5
28
Minocycline Approved, Investigational Phase 4,Phase 3 10118-90-8 5281021
29
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
30
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
31
Sulbactam Approved Phase 4 68373-14-8
32
Cefepime Approved Phase 4 88040-23-7 5479537
33
Tigecycline Approved Phase 4,Phase 3 220620-09-7 5282044
34
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3 616-91-1 12035
35
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 439542 10909430
36
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
37
Dipyridamole Approved Phase 4 58-32-2 3108
38
Warfarin Approved Phase 4 81-81-2 6691 54678486
39
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
40
Lenograstim Approved Phase 4,Phase 2,Phase 3 135968-09-1
41 Nadroparin Approved Phase 4 9041-08-1
42
Dalteparin Approved Phase 4 9041-08-1
43
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
44
Micafungin Approved, Investigational Phase 4 235114-32-6 3081921 477468
45
Teicoplanin Approved Phase 4 61036-62-2
46
Dalbavancin Approved Phase 4 91097-81-3, 171500-79-1 122186
47
Caspofungin Approved Phase 4 179463-17-3, 162808-62-0 468682 2826718
48 tannic acid Approved, Nutraceutical Phase 4
49
Angiotensin II Phase 4 68521-88-0, 11128-99-7 65143 172198
50 Clavulanic Acid Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 214)
id Name Status NCT ID Phase
1 Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Unknown status NCT02175914 Phase 4
2 Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP) Unknown status NCT00761098 Phase 4
3 Probiotics Use in the Chronic Peritoneal Dialysis Patients Unknown status NCT01076426 Phase 4
4 Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis Unknown status NCT01265173 Phase 4
5 Antibiotics Versus Surgery in Acute Appendicitis Unknown status NCT01421901 Phase 4
6 Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis Unknown status NCT00751374 Phase 4
7 Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal Unknown status NCT01059396 Phase 4
8 The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients Unknown status NCT01041963 Phase 4
9 Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Unknown status NCT00313066 Phase 4
10 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4
11 Prospective Comparison of Primary Abdominal Closure and Vacuum Assisted Laparostomy in Treatment of Severe Peritonitis Completed NCT01531543 Phase 4
12 Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis Completed NCT01817309 Phase 4
13 Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis Completed NCT01044446 Phase 4
14 Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis Completed NCT00359853 Phase 4
15 Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs) Completed NCT00481962 Phase 4
16 Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention Completed NCT01542801 Phase 4
17 Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD Completed NCT01637792 Phase 4
18 Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD. Completed NCT00255619 Phase 4
19 Beneficial Effect of Probiotics on Chronic Kidney Disease Completed NCT01391468 Phase 4
20 Use of Ointments in Prevention of Catheter Related Infections in PD Completed NCT00400595 Phase 4
21 Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery Completed NCT00488904 Phase 4
22 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Completed NCT00195351 Phase 4
23 Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children Completed NCT01632046 Phase 4
24 Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial Completed NCT01760967 Phase 4
25 T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam Completed NCT00630513 Phase 4
26 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Completed NCT00230971 Phase 4
27 The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition Completed NCT00966615 Phase 4
28 Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction Completed NCT01315314 Phase 4
29 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
30 IV Antibiotics With Lavage for Severe PD Peritonitis Recruiting NCT02926846 Phase 4
31 Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis Recruiting NCT02872038 Phase 4
32 PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM) Recruiting NCT02277262 Phase 4
33 FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria? Recruiting NCT03029078 Phase 4
34 Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis Recruiting NCT02057679 Phase 4
35 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4
36 Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection Recruiting NCT02547103 Phase 4
37 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection Recruiting NCT02247414 Phase 4
38 Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy Recruiting NCT02238444 Phase 4
39 Straight Versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients Recruiting NCT02479295 Phase 4
40 Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children Recruiting NCT02848820 Phase 4
41 The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites Recruiting NCT02755701 Phase 4
42 Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version Not yet recruiting NCT02354560 Phase 4
43 Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis Not yet recruiting NCT02805049 Phase 4
44 The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels Not yet recruiting NCT02593201 Phase 4
45 Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients Not yet recruiting NCT02940730 Phase 4
46 Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis Terminated NCT00570960 Phase 4
47 The INFECIR-2 Albumin Prevention Study Terminated NCT02034279 Phase 4
48 Method of Exit Site Care in Chronic Peritoneal Dialysis Patients Terminated NCT00416338 Phase 4
49 ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients Terminated NCT00396461 Phase 4
50 Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Withdrawn NCT00463762 Phase 4

Search NIH Clinical Center for Peritonitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Peritonitis

Anatomical Context for Peritonitis

MalaCards organs/tissues related to Peritonitis:

39
Liver, Endothelial, Colon, Kidney, Monocytes, Neutrophil, Small Intestine

Publications for Peritonitis

Articles related to Peritonitis:

(show top 50) (show all 4687)
id Title Authors Year
1
Innovations in Treatment Delivery, Risk of Peritonitis, and Patient Retention on Peritoneal Dialysis. ( 28066919 )
2017
2
A Case of Simultaneous Benign Metastasizing Leiomyomas and Disseminated Peritoneal Leiomyomatosis Following Endoscopic Power Morcellation for Uterine Disease. ( 27748666 )
2017
3
PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum. ( 28079823 )
2017
4
Blocking TGF-I^1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo. ( 28092842 )
2017
5
Chronic peritoneal inflammation and nodules masquerading as peritoneal carcinomatosis in Birt-Hogg-Dube syndrome. ( 28470670 )
2017
6
Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients. ( 28321403 )
2017
7
High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients. ( 28046064 )
2017
8
The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis. ( 28201944 )
2017
9
Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer? Analysis of mucin depletion in two preclinical models. ( 27193208 )
2017
10
Image Findings of Rare Case of Peritoneal Carcinomatosis from Non Small Cell Lung Cancer and Response to Erlotinib in F-18 FDG Positron Emission Tomography/Computed Tomography. ( 28533646 )
2017
11
Exploring possibilities for an alternative approach in experimental schistosomiasis mansoni: the peritoneal cavity of mice. ( 28030359 )
2017
12
Laparoscopic peritoneal lavage for perforated sigmoid diverticulitis: an example of surgical research failure. ( 28067988 )
2017
13
Mesorhizobium peritonitis: The first reported case. ( 28004488 )
2017
14
Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer. ( 28083737 )
2017
15
Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics. ( 27867039 )
2017
16
Peritoneal tuberculosis in patients with rheumatoid arthritis undergoing adalimumab treatment. ( 28527603 )
2017
17
Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment. ( 26857687 )
2017
18
Laparoscopic peritoneal lavage or surgical resection for acute perforated sigmoid diverticulitis: A systematic review and meta-analysis. ( 28089941 )
2017
19
MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitis. ( 28074870 )
2017
20
Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). ( 28516306 )
2017
21
Abnormal peritoneal regulation of chemokine activation-The role of IL-8 in pathogenesis of endometriosis. ( 28120482 )
2017
22
Lower Education Level Is a Risk Factor for Peritonitis and Technique Failure but Not a Risk for Overall Mortality in Peritoneal Dialysis under Comprehensive Training System. ( 28056058 )
2017
23
A study of peritoneal metastatic xenograft model of colorectal cancer in the treatment of hyperthermic intraperitoneal chemotherapy with Raltitrexed. ( 28535418 )
2017
24
Magnetic compression anastomosis for enteroenterostomy under peritonitis conditions in dogs. ( 27993218 )
2017
25
Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer. ( 28075429 )
2017
26
Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. ( 28059968 )
2017
27
Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization-array. ( 27184482 )
2016
28
Hemodialysis Switch Improved Colonic Angiodysplasia in a Peritoneal Dialysis Patient. ( 27659936 )
2016
29
Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues. ( 27152024 )
2016
30
Increased IL-25 levels in the peritoneal fluid of patients with endometriosis. ( 26852387 )
2016
31
Localization of TrkB and p75 receptors in peritoneal and deep infiltrating endometriosis: an immunohistochemical study. ( 27519317 )
2016
32
Spontaneous bacterial peritonitis prevalence in pre-transplant patients and its effect on survival and graft loss post-transplant. ( 28083084 )
2016
33
BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer. ( 26439132 )
2016
34
Idiopathic sclerosing encapsulating peritonitis presenting as a right iliac fossa mass in a teenaged girl. ( 27161205 )
2016
35
Peritoneal dialysis for autosomal dominant polycystic kidney disease: a retrospective study. ( 27143265 )
2016
36
Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer. ( 27665539 )
2016
37
Therapeutic efficacy in vivo of a telomerase-dependent adenovirus in an orthotopic model of chemotherapy-resistant human stomach carcinomatosis peritonitis visualized with cell cycle color coding FUCCI imaging. ( 27171483 )
2016
38
Case Report of a Patient Undergoing Peritoneal Dialysis with Encapsulating Peritoneal Sclerosis Superimposed With Calciphylaxis. ( 27781116 )
2016
39
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report. ( 27902597 )
2016
40
Spontaneous bacterial peritonitis. ( 27570177 )
2016
41
Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer. ( 27315569 )
2016
42
Serendipitous discovery of peritoneal mesothelioma. ( 27034564 )
2016
43
Preventing recurrence of diffuse malignant peritoneal mesothelioma. ( 27486718 )
2016
44
Carbapenem resistant enterobacteriaceae as a cause of peritonitis in a peritoneal dialysis patient. ( 27619106 )
2016
45
EP26.04: Extra ovarian primary peritoneal carcinomaA -A a form of early ovarian cancer? ( 27647734 )
2016
46
Surgical management of a large peritoneal pseudocyst causing acute kidney injury secondary to abdominal compartment syndrome in a rare case of congenital absence of omentum during pregnancy. ( 27630753 )
2016
47
Peritonitis Following Duodenal Ulcer Perforation in a Newborn: A Case Report. ( 28050434 )
2016
48
Successful management of jejunojejunal anastomosis dehiscence by extra-abdominal exteriorization and bandaging in a cat with septic peritonitis. ( 27152038 )
2016
49
Diffuse malignant peritoneal mesothelioma presenting with psammomatous calcification on a cervical smear: A case report. ( 27773157 )
2016
50
Bowel strangulation caused by massive intraperitoneal adhesion due to effective chemotherapy for multiple peritoneal metastases originating from descending colon cancer. ( 27568034 )
2016

Variations for Peritonitis

Expression for Peritonitis

Search GEO for disease gene expression data for Peritonitis.

Pathways for Peritonitis

Pathways related to Peritonitis according to GeneCards Suite gene sharing:

(show top 50) (show all 78)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
14.16 B2M CCL2 CRP CXCL2 CXCL8 ICAM1
2
Show member pathways
13.77 CCL2 CXCL2 CXCL8 F2 IFNG IL10
3
Show member pathways
13.68 CCL2 CXCL8 F2 ICAM1 IFNG IL10
4
Show member pathways
13.55 CCL2 CXCL2 CXCL8 IL10 IL1B IL6
5
Show member pathways
13.49 B2M CCL2 CXCL2 CXCL8 ICAM1 IFNG
6
Show member pathways
13.4 CCL2 CXCL2 CXCL8 IL10 IL1B IL6
7
Show member pathways
13.11 CCL2 CXCL2 CXCL8 IL1B IL6 TLR2
8
Show member pathways
13.07 CCL2 CXCL8 IFNG IL10 IL1B IL6
9
Show member pathways
13.03 B2M CXCL8 ICAM1 IFNG IL10 IL1B
10
Show member pathways
12.96 CCL2 CXCL8 ICAM1 IFNG IL1B IL6
11
Show member pathways
12.79 CXCL8 IFNG IL1B IL6 TNF
12
Show member pathways
12.77 IL1B IL6 TGFB1 TLR2 TNF
13
Show member pathways
12.76 IFNG IL10 IL1B IL6 TGFB1 TLR2
14
Show member pathways
12.76 CCL2 F2 IFNG IL10 IL1B IL6
15 12.71 B2M CCL2 IFNG IL10 IL1B TLR2
16
Show member pathways
12.6 IFNG IL10 IL1B IL6 TGFB1 TNF
17
Show member pathways
12.53 CCL2 CXCL2 CXCL8 IFNG IL1B IL6
18
Show member pathways
12.48 ALB CCL2 CRP F2 ICAM1 IFNG
19
Show member pathways
12.45 IFNG IL10 IL1B ITGAM TGFB1 TLR2
20
Show member pathways
12.44 CXCL8 IFNG IL1B IL6 LBP TNF
21
Show member pathways
12.38 CXCL8 IFNG IL1B IL6 LBP TLR2
22 12.34 IFNG IL6 TGFB1 TLR2 TNF
23
Show member pathways
12.34 CXCL8 IFNG IL10 IL1B IL6 TNF
24 12.34 IFNG IL10 IL1B IL6 ITGAM LBP
25
Show member pathways
12.33 CXCL8 IL6 TLR2 TNF
26 12.33 CXCL8 IL10 IL1B IL6 TNF
27 12.26 CCL2 ICAM1 IFNG IL1B TNF
28 12.17 IFNG IL10 IL6 ITGAM TNF
29 12.16 CCL2 CXCL2 ICAM1 IL1B IL6 TNF
30
Show member pathways
12.16 IFNG IL10 IL1B IL6 TGFB1 TLR2
31 12.15 IFNG IL1B TGFB1 TNF
32 12.12 CXCL8 IFNG IL1B IL6 TGFB1
33
Show member pathways
12.1 IFNG IL1B IL6 TGFB1 TLR2
34 12.1 CXCL2 CXCL8 ICAM1 IL1B LBP TNF
35 12.1 CCL2 CXCL8 ICAM1 IL1B IL6 TGFB1
36 12.08 CCL2 CXCL8 ICAM1 IL10 IL1B IL6
37
Show member pathways
12.05 CXCL8 ICAM1 IL6 LBP TGFB1
38 12.03 CXCL2 CXCL8 IFNG IL1B IL6 LBP
39 12.02 IL1B IL6 ITGAM TNF
40 12 CXCL8 IFNG IL10 IL1B IL6 ITGAM
41 11.98 IFNG IL10 IL1B ITGAM TNF
42 11.97 CXCL8 IL10 IL1B IL6 ITGAM TNF
43 11.96 IFNG IL10 IL1B IL6 ITGAM TGFB1
44 11.94 CXCL8 ICAM1 IFNG IL6
45 11.93 ICAM1 IL10 IL6 TGFB1 TLR2 TNF
46 11.93 AQP1 CCL2 CXCL2 CXCL8 ICAM1 IFNG
47 11.87 CCL2 CXCL2 CXCL8 IL1B IL6 TGFB1
48
Show member pathways
11.85 CXCL2 CXCL8 ICAM1 IFNG IL1B IL6
49
Show member pathways
11.81 CXCL8 IFNG TNF
50 11.75 IFNG IL10 IL6

GO Terms for Peritonitis

Cellular components related to Peritonitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.86 ADA B2M ICAM1 ITGAM LBP TGFB1
2 extracellular region GO:0005576 9.83 ALB B2M CCL2 CRP CXCL2 CXCL8
3 external side of plasma membrane GO:0009897 9.7 ADA B2M F2 ICAM1 IFNG IL6
4 extracellular space GO:0005615 9.58 ADA ALB B2M CCL2 CRP CXCL2
5 extracellular exosome GO:0070062 10.02 ALB AQP1 B2M CRP F2 ICAM1

Biological processes related to Peritonitis according to GeneCards Suite gene sharing:

(show top 50) (show all 86)
id Name GO ID Score Top Affiliating Genes
1 response to wounding GO:0009611 9.98 CCL2 F2 IL6 TGFB1
2 cellular response to interleukin-1 GO:0071347 9.97 CCL2 CXCL8 ICAM1 IL6
3 cellular response to organic cyclic compound GO:0071407 9.97 CCL2 IL1B TGFB1 TNF
4 response to drug GO:0042493 9.97 ADA AQP1 B2M CCL2 ICAM1 IFNG
5 response to glucocorticoid GO:0051384 9.96 CCL2 IL10 IL6 TNF
6 response to insulin GO:0032868 9.95 ICAM1 IL10 IL6 TLR2
7 cellular response to mechanical stimulus GO:0071260 9.94 AQP1 IL1B TGFB1
8 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.94 IL6 TGFB1 TNF
9 chemokine-mediated signaling pathway GO:0070098 9.94 CCL2 CXCL2 CXCL8
10 neutrophil chemotaxis GO:0030593 9.94 CCL2 CXCL8 IFNG IL1B
11 interferon-gamma-mediated signaling pathway GO:0060333 9.93 B2M ICAM1 IFNG
12 regulation of insulin secretion GO:0050796 9.93 IFNG IL1B TNF
13 positive regulation of T cell proliferation GO:0042102 9.93 IFNG IL1B IL6
14 humoral immune response GO:0006959 9.93 CCL2 IFNG IL6 TNF
15 defense response to Gram-negative bacterium GO:0050829 9.92 B2M IL6 LBP
16 T cell activation GO:0042110 9.91 ADA IL6 TGFB1
17 positive regulation of cell adhesion GO:0045785 9.91 CCL2 IFNG TNF
18 positive regulation of tumor necrosis factor production GO:0032760 9.91 CCL2 IFNG LBP TLR2
19 defense response to Gram-positive bacterium GO:0050830 9.91 B2M CRP IL6 LBP TLR2 TNF
20 negative regulation of fat cell differentiation GO:0045599 9.9 IL6 TGFB1 TNF
21 extrinsic apoptotic signaling pathway GO:0097191 9.9 IFNG TGFB1 TNF
22 response to progesterone GO:0032570 9.9 CCL2 TGFB1 TLR2
23 cellular response to estradiol stimulus GO:0071392 9.89 CCL2 IL10 IL6
24 response to amino acid GO:0043200 9.89 CCL2 ICAM1 IL6
25 acute-phase response GO:0006953 9.89 CRP F2 IL6 LBP
26 positive regulation of interleukin-6 production GO:0032755 9.89 IL1B IL6 LBP TLR2 TNF
27 protein import into nucleus, translocation GO:0000060 9.88 IFNG TGFB1 TNF
28 protein kinase B signaling GO:0043491 9.88 CCL2 IL1B TGFB1 TNF
29 positive regulation of nitric oxide biosynthetic process GO:0045429 9.88 ICAM1 IFNG IL1B IL6 TNF
30 positive regulation of neutrophil chemotaxis GO:0090023 9.87 CXCL2 CXCL8 LBP
31 negative regulation of mitotic cell cycle GO:0045930 9.87 IL10 TGFB1 TNF
32 positive regulation of collagen biosynthetic process GO:0032967 9.86 CCL2 F2 TGFB1
33 positive regulation of protein complex assembly GO:0031334 9.86 IFNG TGFB1 TNF
34 positive regulation of NF-kappaB import into nucleus GO:0042346 9.86 IL1B TLR2 TNF
35 positive regulation of interleukin-8 production GO:0032757 9.86 IL1B LBP TLR2 TNF
36 defense response to protozoan GO:0042832 9.85 IFNG IL10 IL6
37 embryonic digestive tract development GO:0048566 9.85 ADA CXCL8 TNF
38 cellular response to dexamethasone stimulus GO:0071549 9.85 AQP1 CCL2 ICAM1 IL6 TGFB1
39 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.83 IFNG IL1B TNF
40 positive regulation of chemokine production GO:0032722 9.83 IL6 LBP TLR2 TNF
41 negative regulation of growth of symbiont in host GO:0044130 9.81 IFNG IL10 LBP TNF
42 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.8 IL10 IL1B TNF
43 positive regulation of chemokine biosynthetic process GO:0045080 9.79 IFNG IL1B TNF
44 negative regulation of lipid storage GO:0010888 9.78 CRP IL6 TNF
45 positive regulation of superoxide anion generation GO:0032930 9.76 CRP TGFB1
46 opsonization GO:0008228 9.75 CRP LBP
47 cellular response to lipoteichoic acid GO:0071223 9.75 LBP TLR2
48 positive regulation of interleukin-6 biosynthetic process GO:0045410 9.75 IFNG IL1B
49 endothelial cell apoptotic process GO:0072577 9.75 IL10 TNF
50 regulation of defense response to virus by host GO:0050691 9.75 IFNG IL1B

Molecular functions related to Peritonitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 glycoprotein binding GO:0001948 9.5 B2M ITGAM TGFB1
2 growth factor activity GO:0008083 9.46 F2 IL10 IL6 TGFB1
3 chemokine activity GO:0008009 9.43 CCL2 CXCL2 CXCL8
4 lipopeptide binding GO:0071723 9.4 LBP TLR2
5 cytokine activity GO:0005125 9.28 CCL2 CXCL2 CXCL8 IFNG IL10 IL1B
6 lipopolysaccharide binding GO:0001530 9.13 F2 LBP TLR2
7 protein binding GO:0005515 10.3 ADA ALB AQP1 B2M CRP CXCL2

Sources for Peritonitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....